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Letters to the Editor
White Cell Count,
Mortality, and Metabolic
Syndrome in the Baltimore
Longitudinal Study of Aging
Ruggiero et al. (1) have shown that higher white cell counts
(WCCs) are associated with higher mortality from both cardio-
vascular disease and cancer. There also was a positive correlation of
the WCC with body mass index and triglyceride levels and a
negative correlation with physical activity. Waist circumference,
waist-to-hip ratio, or high-density lipoprotein levels were not
recorded in this study. We believe that if the criteria to diagnose
the metabolic syndrome were available they would have explained
the elevated WCC, and that the presence of the metabolic
syndrome likely would have been the causal factor for both the
elevated WCC and the increased mortality.
The metabolic syndrome is an inflammatory state associated
with an elevated WCC caused by leucocyte infiltration of an
increased mass of intraperitoneal fat. Pickup et al. (2) in 1998
provided evidence that type 2 diabetes was associated with in-
creased concentrations of markers of the acute-phase response,
including sialic acid, alpha-1 acid glycoprotein, amyloid A,
C-reactive protein, and cortisol. The major cytokine involved in
this inflammatory state is interleukin-6, which stimulates hepatic
production of C-reactive protein (3). Recently, Tsai et al. (4) have
shown that after adjustment for age, gender, and other known risk
factors, the greater the number of features of the metabolic
syndrome that are present, the higher were the total leukocyte,
monocyte, neutrophil, and lymphocyte counts and the higher was
the risk of ischemic cardiovascular disease in patients with type 2
diabetes. Similarly, Shim et al. (5) have shown that the greater the
number of components of the metabolic syndrome, the more
elevated was the WCC.
Although obesity, without features of the metabolic syndrome,
has been shown to be associated with an increased WCC, Desai
et al. (6) showed that the association of the leukocyte count with
obesity is highly dependent on the presence of the metabolic
syndrome. In the National Health and Nutrition Examination
Survey, an elevated WCC was independently associated with
insulin resistance (7).
Therefore, we believe that the association between an elevated
WCC and mortality simply reflects the co-association between the
metabolic syndrome and mortality. Had assessments of waist-to-
hip ratio and the triglyceride-to-high-density lipoprotein ratio
been available, we believe that this relationship would have been
apparent.
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Reply
We thank Drs. Bell and O’Keefe for the interest in our study about
the relationship between the white blood cell (WBC) count and
mortality over the period 1958 to 2002 (1).
Drs. Bell and O’Keefe point out that the metabolic syndrome
(MetS) could mediate the relationship between elevated WBC count
and increased mortality shown in our study. Although we find this
hypothesis interesting, we do not have adequate data to address it in
the BLSA (Baltimore Longitudinal Study of Aging). Information on
the components of the MetS were not systematically collected over
the period 1958 to 2002, and therefore we could not explore possible
secular trends for this syndrome. Although the mortality risk ratio
between WBC groups was adjusted for some components of MetS,
such as triglycerides, blood pressure, and diabetes status, we could not
investigate the role of waist circumference, waist-to-hip ratio, or
high-density lipoprotein levels. Data on waist circumference were
available for a small subgroup of the BLSA study population, and
high-density lipoprotein was measured starting in the mid-1980s.
Other longitudinal studies exist that collected information on the
MetS and may better discern whether the presence of MetS is causal
in both the elevated WBC count and the increased mortality.
The finding that WBC count is nonlinearly associated with
all-cause mortality and almost linearly associated with cardiovascular
mortality, while there is no significant association between WBC
count and cancer mortality, supports hypotheses that elevated WBC
count may be part of a cluster of risk factors that predispose an
individual to cardiovascular morbidity and mortality (2). However,
whether this cluster corresponds to the MetS is still uncertain.
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The finding that secular mortality decline is at least in part
independent of WBC secular downward trend suggests that other
factors, such as the changes in the treatment of inflammatory-related
conditions and cardiovascular risk factors, should be considered.
Finally, the relationship between the MetS and inflammatory
status is not crystal clear. There are several studies showing a
cross-sectional association between MetS and WBC count, but
limited evidence suggesting that the MetS may cause an increase in
WBC count (3,4). On the other hand, other lines of research have
shown that chronic inflammation and elevated WBC count
contribute to the development of MetS. A chronic low-grade
inflammation seems to be a key factor underlying the cluster of
MetS components, such as atherogenetic dyslipidemia, elevated
blood pressure, elevated plasma glucose (5,6), and also is a
recognized risk factor for cardiovascular disease and type 2 diabetes
(7). Moreover, elevated C-reactive protein (CRP) levels have been
significantly associated with each component of MetS (8), and
elevated levels of high-sensitivity CRP has been found to predict
MetS (7). Considering that WBC count and CRP are both
markers of inflammation, and that WBC by producing
interleukin-6 stimulates the hepatic synthesis of CRP (10), we
suggest that WBC count may be an index of the inflammatory
status associated with subclinical levels of each component of
MetS. We are collecting data in the BLSA that will be helpful to
better clarify the relationship between WBC and the occurrence of
each component of MetS in older adults. (9).
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